Ballieu have released today (20 April) a research paper on KAR that maintains a Hold recommendation with a price target of $11.20. It should be noted & I think most of us appreciate that it is categorized as High Risk. The say that if Kronos 1 is a success the valuation range is $11.33 > $17.00. They acknowledge that testing will take 30 - 40 days & investors need be patient. They make the point that even in the event that Kronos 1 is not successful, long term investors should accumulate below $7.00.
ballieu research
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add KAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.74 |
Change
-0.060(3.34%) |
Mkt cap ! $1.393B | |||
| Open | High | Low | Value | Volume |
| $1.77 | $1.78 | $1.71 | $10.73M | 6.209M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7057 | $1.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.74 | 74166 | 5 |
View Market Depth
| Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
| KAR (ASX) Chart |